Clifford Swan Investment Counsel LLC Eli Lilly & CO Transaction History

Clifford Swan Investment Counsel LLC

$2.68 Billion
Q1 2024

A detailed history of Clifford Swan Investment Counsel LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clifford Swan Investment Counsel LLC holds 5,033 shares of LLY stock, worth $4.6 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

5,033

Previous 5,084 1.0%

Holding current value

$4.6 Million

Previous $2.96 Million 32.13%

% of portfolio

0.15%

Previous 0.12%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $30,202 - $40,406	-51 Reduced 1.0%	5,033 $3.92 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $130,247 - $153,544	-248 Reduced 4.65%	5,084 $2.96 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $7,824 - $10,787	18 Added 0.34%	5,332 $2.86 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $205,182 - $274,353	585 Added 12.37%	5,314 $2.49 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $125,183 - $147,022	-403 Reduced 7.85%	4,729 $1.62 Million

Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $5,787 - $6,744	-18 Reduced 0.35%	5,132 $1.88 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $18,396 - $21,599	66 Added 1.3%	5,150 $1.67 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $35,203 - $43,749	-150 Reduced 2.87%	5,084 $1.46 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $15,739 - $19,532	-70 Reduced 1.32%	5,234 $1.45 Million
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $44,320 - $54,541	200 Added 3.92%	5,304 $1.23 Million
Q2 2021 Aug 05, 2021	SELL	$180.55 - $233.54 $4,513 - $5,838	-25 Reduced 0.49%	5,104 $1.34 Million
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $4,108 - $5,318	-25 Reduced 0.49%	5,129 $958,000
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $9,914 - $13,119	-76 Reduced 1.45%	5,154 $870,000
Q3 2020 Oct 30, 2020	BUY	$146.22 - $169.13 $146 - $169	1 Added 0.02%	5,230 $774,000
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $8,185 - $9,850	-60 Reduced 1.13%	5,229 $858,000
Q1 2020 Apr 09, 2020	BUY	$119.05 - $147.35 $8,333 - $10,314	70 Added 1.34%	5,289 $734,000
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $33,347 - $38,925	-301 Reduced 5.45%	5,219 $578,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $144,703 - $170,326	-1,300 Reduced 19.06%	5,520 $716,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $2,647 - $2,966	-25 Reduced 0.37%	6,820 $789,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $44,647 - $55,801	-520 Reduced 7.06%	6,845 $735,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $49,583 - $56,906	-655 Reduced 8.17%	7,365 $628,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $26,715 - $31,535	-360 Reduced 4.3%	8,020 $621,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $81,940 - $87,890	1,000 Added 13.55%	8,380 $708,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $14,643 - $16,252	190 Added 2.64%	7,380 $631,000
Q2 2017 Aug 11, 2017	BUY	N/A	7,190	7,190 $592,000

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clifford Swan Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clifford Swan Investment Counsel LLC with notifications on news.

Account

Clifford Swan Investment Counsel LLC Eli Lilly & CO Transaction History